Treatment Effects on Chronic Active Lesions in Multiple Sclerosis: Current Evidence and Future Perspectives
Abstract
Introduction: Multiple sclerosis (MS) is characterized by chronic, compartmentalized inflammation persisting behind a relatively intact blood-brain barrier. This process can be assessed in vivo using neuroimaging biomarkers of chronic active lesions (CALs): paramagnetic rim lesions (PRLs), slowly expanding lesions (SELs), and lesions showing increased uptake of 18-kDa translocator protein (TSPO) positron emission tomography (PET) tracers. Given their association with more severe structural damage, clinical disability, and disease progression, CALs represent a biologically relevant target to assess whether disease-modifying therapies (DMTs) can modulate smoldering MS pathology.
Methods: This narrative review summarizes current evidence on the effects of DMTs on CAL-associated imaging biomarkers and discusses implications for future clinical trial design targeting smoldering MS biology.
Results: Despite their strong biological and clinical relevance, current evidence suggests that available DMTs have a limited and inconsistent effect on CAL occurrence and evolution over short- to medium-term follow-up. However, treatment effects may be more apparent at the microstructural level, potentially attenuating intralesional progressive microstructural damage accumulation. Interpretation of existing data is challenged by heterogeneous MS cohorts, variability in imaging methodologies, short follow-up durations, and the only partial biological overlap among PRLs, SELs, and TSPO-PET…
Read the paper
Related studies
- A Survey on Knowledge Graphs: Representation, Acquisition, and Applications
- Toxicity of nanomaterials
- The Human Gene Mutation Database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies
- Halogen bonding (X‐bonding): A biological perspective
- Biofilm formation at the air–liquid interface by the Pseudomonas fluorescens SBW25 wrinkly spreader requires an acetylated form of cellulose
- Opioid Activation of Toll-Like Receptor 4 Contributes to Drug Reinforcement
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.